Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. vs COLINZ LABOR - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MARKSANS PHARMA. COLINZ LABOR MARKSANS PHARMA./
COLINZ LABOR
 
P/E (TTM) x 21.5 19.9 107.8% View Chart
P/BV x 3.9 1.2 338.6% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 MARKSANS PHARMA.   COLINZ LABOR
EQUITY SHARE DATA
    MARKSANS PHARMA.
Mar-23
COLINZ LABOR
Mar-23
MARKSANS PHARMA./
COLINZ LABOR
5-Yr Chart
Click to enlarge
High Rs7461 121.7%   
Low Rs3924 164.7%   
Sales per share (Unadj.) Rs40.928.3 144.7%  
Earnings per share (Unadj.) Rs5.91.8 322.9%  
Cash flow per share (Unadj.) Rs7.02.3 301.0%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs38.532.3 119.2%  
Shares outstanding (eoy) m453.162.52 17,982.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.41.5 92.4%   
Avg P/E ratio x9.723.3 41.5%  
P/CF ratio (eoy) x8.118.2 44.4%  
Price / Book Value ratio x1.51.3 112.1%  
Dividend payout %8.50-   
Avg Mkt Cap Rs m25,631107 24,039.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2,39429 8,265.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m18,52171 26,016.8%  
Other income Rs m5932 34,484.3%   
Total revenues Rs m19,11573 26,216.6%   
Gross profit Rs m3,3936 55,717.7%  
Depreciation Rs m5191 40,196.1%   
Interest Rs m911 17,553.8%   
Profit before tax Rs m3,3776 56,275.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7231 50,938.0%   
Profit after tax Rs m2,6535 58,057.1%  
Gross profit margin %18.38.6 214.2%  
Effective tax rate %21.423.7 90.3%   
Net profit margin %14.36.4 223.0%  
BALANCE SHEET DATA
Current assets Rs m16,99778 21,693.2%   
Current liabilities Rs m3,65419 19,372.0%   
Net working cap to sales %72.083.6 86.2%  
Current ratio x4.74.2 112.0%  
Inventory Days Days635 16.2%  
Debtors Days Days82581 14.1%  
Net fixed assets Rs m5,24624 21,893.7%   
Share capital Rs m45325 1,799.0%   
"Free" reserves Rs m16,99856 30,246.4%   
Net worth Rs m17,45281 21,442.0%   
Long term debt Rs m00-   
Total assets Rs m22,242102 21,740.2%  
Interest coverage x38.012.5 303.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.7 119.7%   
Return on assets %12.35.0 247.7%  
Return on equity %15.25.6 270.5%  
Return on capital %19.98.0 248.0%  
Exports to sales %00-   
Imports to sales %7.30-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m1,348NA-   
Fx inflow Rs m6,4910-   
Fx outflow Rs m1,3480-   
Net fx Rs m5,1430-   
CASH FLOW
From Operations Rs m2,3744 58,911.2%  
From Investments Rs m-2,592NA -2,880,133.3%  
From Financial Activity Rs m1,9781 178,224.3%  
Net Cashflow Rs m1,7605 33,657.9%  

Share Holding

Indian Promoters % 43.9 66.0 66.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 20.3 0.0 -  
FIIs % 15.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 56.2 34.0 165.1%  
Shareholders   237,377 2,915 8,143.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MARKSANS PHARMA. With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on MARKSANS PHARMA. vs COLINZ LABOR

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MARKSANS PHARMA. vs COLINZ LABOR Share Price Performance

Period MARKSANS PHARMA. COLINZ LABOR S&P BSE HEALTHCARE
1-Day 0.46% -1.65% 1.18%
1-Month -0.72% -7.97% -0.75%
1-Year 109.61% 4.31% 61.82%
3-Year CAGR 45.11% 70.32% 18.16%
5-Year CAGR 43.62% 41.97% 19.79%

* Compound Annual Growth Rate

Here are more details on the MARKSANS PHARMA. share price and the COLINZ LABOR share price.

Moving on to shareholding structures...

The promoters of MARKSANS PHARMA. hold a 43.9% stake in the company. In case of COLINZ LABOR the stake stands at 66.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MARKSANS PHARMA. and the shareholding pattern of COLINZ LABOR.

Finally, a word on dividends...

In the most recent financial year, MARKSANS PHARMA. paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 8.5%.

COLINZ LABOR paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of MARKSANS PHARMA., and the dividend history of COLINZ LABOR.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.